Evidence map›Paper›PMID 29922166›Full record

ArticleFrontiers in pharmacology2018

Isoquinoline Alkaloids and Indole Alkaloids Attenuate Aortic Atherosclerosis in Apolipoprotein E Deficient Mice: A Systematic Review and Meta-Analysis.

Yibing Zhang, Min Li, Xiangjun Li, Tong Zhang, Meng Qin, Liqun Ren

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. The Potency ofFrontiers in pharmacology · 2021
    Review
  7. Microbiota-Mediated Immune Regulation in Atherosclerosis.Molecules (Basel, Switzerland) · 2021
    Review
  8. Antimalarial Properties of Isoquinoline Derivative fromBioMed research international · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yibing ZhangDepartment of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Jilin University, Changchun, China.
Min LiDepartment of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Jilin University, Changchun, China.
Xiangjun LiDepartment of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Jilin University, Changchun, China.
Tong ZhangDepartment of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Jilin University, Changchun, China.
Meng QinDepartment of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Jilin University, Changchun, China.
Liqun RenDepartment of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Jilin University, Changchun, China.
Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

alkaloidApoE deficient mouseatherosclerosismeta-analysisnatural compounds

Identifiers

PMID29922166
PMCPMC5996168
OpenAlexW2805878340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.